| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/04/2010 | WO2010022412A1 Octahydroquinolizines for antidiabetic treatment |
| 03/04/2010 | WO2010004215A3 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 03/04/2010 | WO2009106471A3 Angiotensin ii receptor blocker derivatives |
| 03/04/2010 | US20100056796 Compounds Suitable As Precursors to Compounds that are Useful for Imaging Amyloid Deposits |
| 03/04/2010 | US20100056779 Synthesis of methyl nonactate derivatives |
| 03/04/2010 | US20100056602 Substituted Pyrrole Derivatives And Their Use As HMG-CO Inhibitors |
| 03/04/2010 | US20100056582 Modulators of LXR |
| 03/04/2010 | US20100056571 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors |
| 03/04/2010 | US20100056528 Sulfonamide derivatives with therapeutic indications |
| 03/04/2010 | US20100056512 Pyrimidine compounds |
| 03/04/2010 | US20100056506 Substituted 2-amino-fused heterocyclic compounds |
| 03/04/2010 | CA2735730A1 2,4-diaminopyrimidine compound |
| 03/04/2010 | CA2735497A1 New compounds suitable as precursors to compounds that are useful for imaging amyloid deposits |
| 03/04/2010 | CA2734981A1 Oxotetrahydrofuran-2-yl-benzimidazole derivative |
| 03/04/2010 | CA2734551A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors |
| 03/04/2010 | CA2733648A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 03/03/2010 | EP2159223A2 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators |
| 03/03/2010 | EP2081572B1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 03/03/2010 | EP2016064B1 Methods for the preparation of pyrazole-containing compounds |
| 03/03/2010 | EP1753719B1 Substituted pyrrolidine-2-ones |
| 03/03/2010 | EP1749001B1 3-piperidinylisochroman-5-ols as dopamine agonists |
| 03/03/2010 | EP1107964B1 Isoquinoline derivatives with angiogenesis inhibiting activity |
| 03/03/2010 | CN101663296A Twelve-membered cyclomacrolactam derivative |
| 03/03/2010 | CN101659659A Pyridine derivative and medical application thereof |
| 03/02/2010 | US7671221 Modulators of ATP-Binding Cassette transporters |
| 03/02/2010 | US7671088 Water-soluble etoposide analogs and methods of use thereof |
| 03/02/2010 | US7671076 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 03/02/2010 | US7671072 benzyl-carbamic acid cis-3-[5-(cyclohexanecarbonyl-amino)-1H-pyrazol-3-yl]-cyclobutyl ester; glycogen synthase kinase-3 (GSK-3) inhibitors; inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke |
| 03/02/2010 | US7671063 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors |
| 03/02/2010 | US7671056 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline; central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction |
| 03/02/2010 | US7671053 such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide for treatment of asthma and COPD; purinergic receptors (P2X7) |
| 03/02/2010 | US7671049 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases |
| 03/02/2010 | US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV) |
| 03/02/2010 | CA2445207C Process for the preparation of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman |
| 02/25/2010 | WO2010022125A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | WO2010022121A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | WO2010021878A1 Cold menthol receptor antagonists |
| 02/25/2010 | WO2010020548A1 Glyt1 receptor antagonists |
| 02/25/2010 | WO2009091433A3 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048636 Aspartic Protease Inhibitors |
| 02/25/2010 | US20100048618 Derivatives of 8-epiblechnic Acid and their Effects on Down-Regulation of Endothelin (ETA) receptor mRNA |
| 02/25/2010 | US20100048600 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048585 Quinoline derivatives as antibacterial agents |
| 02/25/2010 | US20100048565 Benzimidazole derivatives |
| 02/25/2010 | US20100048539 Compounds and compositions as protein kinase inhibitors |
| 02/25/2010 | US20100048531 GlyT1 RECEPTOR ANTAGONISTS |
| 02/25/2010 | US20100048529 New 2-Azetidinone Derivatives Useful In The Treatment Of Hyperlipidaemic Conditions |
| 02/25/2010 | US20100048500 Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections |
| 02/25/2010 | CA2734487A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/25/2010 | CA2734486A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 02/24/2010 | EP2157084A1 5-phenyl-3-pyridazinone derivative |
| 02/24/2010 | EP2157081A1 Indolinones substituted in six locations, their manufacture and their application as medicine |
| 02/24/2010 | EP2155732A1 Amorphous olmesartan medoxomil |
| 02/24/2010 | EP2155731A1 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase |
| 02/24/2010 | EP2155717A1 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists |
| 02/24/2010 | EP2155716A2 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 02/24/2010 | EP2155714A2 Substituted aromatic heterocyclic compounds as fungicides |
| 02/24/2010 | EP2155693A1 Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology |
| 02/24/2010 | EP2155666A1 Azetidine derivatives and their use as prostaglandin e2 antagonists |
| 02/24/2010 | EP2154966A1 Benzimidazoles and pharmaceutical compositions thereof |
| 02/24/2010 | EP2001873B1 Active ingredient combinations with insecticidal properties |
| 02/24/2010 | EP1981880B1 Use of 4-imidazole derivatives for cns disorders |
| 02/24/2010 | EP1848705B1 Exo- and diastereo- selective syntheses of himbacine analogs |
| 02/24/2010 | EP1748995B1 Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both |
| 02/24/2010 | EP1742935B1 Polycyclic pyrazines as potassium ion channel modulators |
| 02/24/2010 | EP1729775B1 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin |
| 02/24/2010 | EP1682539B1 Process for preparing thiazolidinediones |
| 02/24/2010 | EP1625121B1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/24/2010 | EP1585728B1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases |
| 02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 02/24/2010 | CN101657444A Derivatives and analogs of chroman as functionally selective alpha2C adrenoreceptor agonists |
| 02/24/2010 | CN101657443A [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 02/24/2010 | CN101654453A Process for the manufacture of the calcium salt of rosuvatatin and crystalline intermediates thereof |
| 02/24/2010 | CN100591676C 2- and 2,5-substituted phenylketo-enols |
| 02/23/2010 | USRE41149 Optically active pyridonecarboxylic acid derivatives |
| 02/23/2010 | US7667053 Cannabinoid-1 (CB1) receptor antagonists and/or inverse agonists; e.g. N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1,4-benzodioxane-2-carboxamide; psychological disorders, eating disorders |
| 02/23/2010 | US7667052 Bioactive substance |
| 02/23/2010 | US7667041 Cinnamide compound |
| 02/23/2010 | US7666904 3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/23/2010 | US7666869 Nitrogen-containing 5-membered ring compound |
| 02/23/2010 | US7666863 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
| 02/23/2010 | CA2462289C Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 02/23/2010 | CA2433021C Isoindole-imide compounds, compositions, and uses thereof |
| 02/23/2010 | CA2374905C Pyrrolidinyl, piperidinyl or homopiperidinyl-substituted benzopyran derivatives for treating impaired fundic relaxation |
| 02/23/2010 | CA2345146C Cyanophenyl derivative |
| 02/18/2010 | WO2010019930A1 Urea derivatives as inhibitors of map kinases |
| 02/18/2010 | WO2010018874A1 Amide compound |
| 02/18/2010 | WO2010018777A1 Odor-controlling method |
| 02/18/2010 | WO2010018231A2 Salt of, and processes for the preparation of, 1-isopropyl-4-{[4-(tetrahydro-2h-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1h-1,4-diazepine |
| 02/18/2010 | WO2010017827A1 6-substituted 1-sulfonyl-2, 3-dihydro-indole derivatives for the treatment of proliferative diseases |
| 02/18/2010 | WO2009084773A3 Preparation process useful in synthesis of atorvastatin |
| 02/18/2010 | US20100041708 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for it's preparation |
| 02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
| 02/18/2010 | US20100041654 Pyrimidine Derivatives And Their Use As CB2 Modulators |
| 02/18/2010 | US20100041652 Tyrosine kinase inhibitors |
| 02/18/2010 | US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth |